These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6175933)

  • 21. Methotrexate, bleomycin, and high-dose-cis-dichlorodiammineplatinum(II) in the treatment of advanced epidermoid carcinoma of the head and neck.
    Caradonna R; Paladine W; Ruckdeschel JC; Goldstein JC; Olson JE; Jaski JW; Silvers SA; Hillinger S; Horton J
    Cancer Treat Rep; 1979 Mar; 63(3):489-91. PubMed ID: 85494
    [No Abstract]   [Full Text] [Related]  

  • 22. Combined chemotherapy of head and neck squamous cell carcinomas with methotrexate, bleomycin, and hydroxyurea.
    Medenica R; Alberto P; Lehmann W
    Cancer Chemother Pharmacol; 1981; 5(3):145-9. PubMed ID: 6170472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Initial experiences with a new treatment protocol in otorhinolaryngologic cancers].
    Lehnert M; Jakse R; Scherlacher A; Tschech G
    Acta Med Austriaca Suppl; 1979; 6():337-9. PubMed ID: 95541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapy in head and neck cancer.
    Hong WK; Bromer R
    N Engl J Med; 1983 Jan; 308(2):75-9. PubMed ID: 6183588
    [No Abstract]   [Full Text] [Related]  

  • 25. Vinblastine, methotrexate, bleomycin, in the management of head and neck cancer.
    Vanhaelen C; Bertrand M; De Jager R; Kenis Y
    Eur J Cancer (1965); 1979 Nov; 15(11):1315-8. PubMed ID: 93540
    [No Abstract]   [Full Text] [Related]  

  • 26. Recurrent and/or metastatic head and neck squamous cell carcinoma: a clinical, univariate and multivariate analysis of response and survival with cisplatin-based chemotherapy.
    Recondo G; Armand JP; Tellez-Bernal E; Domenge C; Belehradek M; De Vathaire F; Wibault P; Richard JM; Cvitkovic E
    Laryngoscope; 1991 May; 101(5):494-501. PubMed ID: 1709437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II trial of vindesine in patients with squamous cell cancer of the head and neck.
    Sledge GW; Clark GM; Griffin C; Mattox DE; Von Hoff DD
    Am J Clin Oncol; 1984 Jun; 7(3):209-11. PubMed ID: 6731343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chemotherapy of advanced head and neck cancer with a combination of bleomycin, vincristine, methotrexate and hydroxyuree or cis-dichloro-diamino-platinium. Analysis of local and general parameters of prognosis (author's transl)].
    Pouillart P; Palangie T; Garcia-Giralt E; Jouve M; Bataini JP; Jaulerry M; Brugère J; Asselin B
    Bull Cancer; 1980; 67(3):269-80. PubMed ID: 6157447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vinblastine, bleomycin and cisplatin for recurrent or metastatic squamous cell carcinoma of the head and neck.
    Perry DJ; Weltz MD; Brown AW; Henderson RL; Neglia WJ; Berenberg JL
    Cancer; 1982 Dec; 50(11):2257-60. PubMed ID: 6182971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of recurrent head and neck cancer with cisplatin and 5-fluorouracil vs. the same plus bleomycin and methotrexate.
    Amrein PC; Fabian RL
    Laryngoscope; 1992 Aug; 102(8):901-6. PubMed ID: 1379664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotherapy of squamous cell carcinoma of the head and neck.
    Greenberg BR
    Ariz Med; 1985 Jul; 42(7):411-7. PubMed ID: 2412534
    [No Abstract]   [Full Text] [Related]  

  • 32. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.
    Le Chevalier T; Pujol JL; Douillard JY; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S; Besson F
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antineoplastic chemotherapy of head and neck tumors (author's transl)].
    Weidauer H
    HNO; 1981 Nov; 29(11):374-80. PubMed ID: 6171551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Combined radiotherapy with cis- or carboplatin in advanced head and neck tumors].
    Zamboglou N; Pape H; Schnabel T; Wurm R; Bannach B; Fürst G; Schmitt G
    Strahlenther Onkol; 1989 Sep; 165(9):647-51. PubMed ID: 2678546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methotrexate, vinblastine, epidoxorubicin, and bleomycin as second-line chemotherapy for recurrent and/or metastatic squamous cell carcinoma of the head and neck.
    Gebbia V; Valenza R; Testa A; Borsellino N; Cannata G; Restivo S; Speciale R; Ingria F; Spadafora G; Gebbia N
    ORL J Otorhinolaryngol Relat Spec; 1994; 56(5):279-82. PubMed ID: 7526312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitomycin-C, methotrexate, bleomycin and cis-diamminedichloroplatinum II in the chemotherapy of advanced squamous cancer of the head and neck.
    Vogl SE; Lerner H; Kaplan BH; Camacho F; Cinberg J; Schoenfeld D
    Cancer; 1982 Jul; 50(1):6-9. PubMed ID: 6177393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemotherapy in recurrent heat and neck cancer.
    Simmonds WP
    Otolaryngol Clin North Am; 1974 Feb; 7(1):205-15. PubMed ID: 4130287
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of esophageal carcinoma combined preoperative chemotherapy.
    Bains MS; Kelsen DP; Beattie EJ; Martini N
    Ann Thorac Surg; 1982 Nov; 34(5):521-8. PubMed ID: 6182844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Results of a low-dose combination chemotherapy with vincristine, bleomycin and methotrexate (V-B-M) based on cell kinetics in the palliative treatment of head and neck squamous cell carcinoma.
    Molinari R; Mattavelli F; Cantù G; Chiesa F; Costa L; Tancini G
    Eur J Cancer (1965); 1980 Apr; 16(4):469-72. PubMed ID: 6156839
    [No Abstract]   [Full Text] [Related]  

  • 40. Cis-dichlorodiammineplatinum(II), methotrexate, bleomycin, and vincristine in head and neck cancer: a pilot study.
    King GW; Halpin JJ; Smith RE; Batley F; Schuller DE
    Cancer Treat Rep; 1979; 63(11-12):1735-8. PubMed ID: 93508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.